🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/08/2007 | 33,50 | 33,99 | 33,35 | 33,91 | +0,79% | 1,90% | 438.200 |
| 24/08/2007 | 33,93 | 33,98 | 33,53 | 33,65 | -0,97% | 1,34% | 888.400 |
| 23/08/2007 | 33,37 | 34,00 | 33,25 | 33,98 | +2,47% | 2,26% | 827.000 |
| 22/08/2007 | 33,25 | 33,35 | 32,89 | 33,16 | +0,41% | 1,38% | 539.600 |
| 21/08/2007 | 32,76 | 33,15 | 32,55 | 33,02 | +0,24% | 1,83% | 1.676.400 |
| 20/08/2007 | 32,53 | 32,95 | 32,46 | 32,94 | +1,26% | 1,52% | 1.269.600 |
| 17/08/2007 | 33,00 | 33,03 | 32,26 | 32,53 | +0,90% | 2,35% | 1.899.400 |
| 16/08/2007 | 32,12 | 32,47 | 31,82 | 32,24 | -0,31% | 2,04% | 1.204.400 |
| 15/08/2007 | 32,35 | 32,88 | 32,30 | 32,34 | -0,80% | 1,78% | 866.200 |
| 14/08/2007 | 33,04 | 33,04 | 32,34 | 32,60 | -0,79% | 2,13% | 909.600 |
| 13/08/2007 | 33,26 | 33,62 | 32,79 | 32,86 | -0,62% | 2,50% | 933.600 |
| 10/08/2007 | 33,76 | 33,87 | 32,93 | 33,07 | -3,12% | 2,78% | 2.180.600 |
| 09/08/2007 | 33,82 | 34,18 | 33,72 | 34,13 | -0,19% | 1,35% | 2.236.600 |
| 08/08/2007 | 33,87 | 34,24 | 33,80 | 34,20 | +1,60% | 1,30% | 2.054.800 |
| 07/08/2007 | 33,62 | 33,83 | 33,42 | 33,66 | -0,41% | 1,22% | 1.952.400 |
| 06/08/2007 | 34,36 | 34,40 | 33,59 | 33,80 | -1,50% | 2,37% | 2.328.800 |
| 03/08/2007 | 34,72 | 34,78 | 34,01 | 34,31 | -1,66% | 2,20% | 1.883.000 |
| 02/08/2007 | 34,65 | 35,22 | 34,63 | 34,89 | -0,11% | 1,70% | 1.420.400 |
| 01/08/2007 | 35,06 | 35,22 | 34,60 | 34,93 | +0,72% | 1,77% | 1.661.200 |
| 31/07/2007 | 35,74 | 36,17 | 34,50 | 34,68 | -0,67% | 4,67% | 3.815.000 |
| 30/07/2007 | 34,72 | 35,05 | 34,69 | 34,92 | +0,26% | 1,05% | 3.138.200 |
| 27/07/2007 | 34,81 | 34,99 | 34,59 | 34,83 | -0,37% | 1,16% | 2.350.600 |
| 26/07/2007 | 34,54 | 35,00 | 34,46 | 34,96 | +0,95% | 1,56% | 2.012.600 |
| 25/07/2007 | 34,87 | 34,95 | 34,37 | 34,63 | -0,07% | 1,65% | 1.939.000 |
| 24/07/2007 | 34,94 | 34,94 | 34,53 | 34,65 | -0,39% | 1,19% | 1.035.200 |
| 23/07/2007 | 34,92 | 34,99 | 34,50 | 34,79 | +0,22% | 1,40% | 1.616.600 |
| 20/07/2007 | 34,69 | 34,98 | 34,59 | 34,71 | -0,03% | 1,12% | 1.356.600 |
| 19/07/2007 | 34,67 | 34,97 | 34,59 | 34,72 | +0,26% | 1,10% | 3.160.600 |
| 18/07/2007 | 34,45 | 34,77 | 34,26 | 34,63 | +0,38% | 1,48% | 1.508.600 |
| 17/07/2007 | 33,95 | 34,68 | 33,95 | 34,50 | +1,41% | 2,15% | 2.157.400 |